Pattern recognition by B cells: the role of antigen repetitiveness versus Toll-like receptors. by Hinton, H, Jegerlehner, A, Bachmann, M

Toll-like receptor 7 signaling drives IgA responses by Bessa, J, Jegerlehner, A, Bachmann, M

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. by Jegerlehner, A, Schmitz, N, Storni, T, Bachmann, M

Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1. by Gatto, D, Pfister, T, Jegerlehner, A, Martin, S, Kopf, M, Bachmann, M

Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses by Bessa, J, Jegerlehner, A, Hinton, H, Schneider, P, Bachmann, M

Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies. by Ruedl, C, Schwarz, K, Jegerlehner, A, Storni, T, Manolova, V, Bachmann, M

TLR9 signaling in B cells determines class switch recombination to IgG2a by Jegerlehner, A, Maurer, P, Bessa, J, Hinton, H, Kopf, M, Bachmann, M

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design. by Bessa, J, Schmitz, N, Hinton, H, Schwarz, K, Jegerlehner, A, Bachmann, M

TLR9 signaling in B cells determines class switch recombination to IgG2a. by Jegerlehner, A, Maurer, P, Bessa, J, Hinton, H, Kopf, M, Bachmann, M

Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles. by Storni, T, Lechner, F, Erdmann, I, Bächi, T, Jegerlehner, A, Dumrese, T, Kündig, T, Ruedl, C, Bachmann, M

Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses. by Bessa, J, Jegerlehner, A, Hinton, H, Pumpens, P, Saudan, P, Schneider, P, Bachmann, M

Bacterially produced recombinant influenza vaccines based on virus-like particles by Jegerlehner, A, Zabel, F, Langer, A, Dietmeier, K, Jennings, G, Saudan, P, Bachmann, M

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies. by Jegerlehner, A, Wiesel, M, Dietmeier, K, Zabel, F, Gatto, D, Saudan, P, Bachmann, M

Virus-like particles as a modular system for novel vaccines. by Lechner, F, Jegerlehner, A, Tissot, A, Maurer, P, Sebbel, P, Renner, W, Jennings, G, Bachmann, M

Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection. by Schmitz, N, Beerli, R, Bauer, M, Jegerlehner, A, Dietmeier, K, Maudrich, M, Pumpens, P, Saudan, P, Bachmann, M

Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses. by Bessa, J, Zabel, F, Link, A, Jegerlehner, A, Hinton, H, Schmitz, N, Bauer, M, Kündig, T, Saudan, P, Bachmann, M

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. by Jegerlehner, A, Tissot, A, Lechner, F, Sebbel, P, Erdmann, I, Kündig, T, Bächi, T, Storni, T, Jennings, G, Pumpens, P, Renner, W, Bachmann, M

Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine by Skibinski, D, Hanson, B, Lin, Y, Von Messling, V, Jegerlehner, A, Tee, J, Chye, D, Wong, S, Ng, A, Lee, H, Au, B, Lee, B, Santoso, L, Poidinger, M, Fairhurst, A, Matter, A, Bachmann, M, Saudan, P, Connolly, J